Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG

Inclusion Criteria:

1. Patient with lung cancer at any diagnostic stage and histology.

2. Patient willing to use the follow-up setting with Moovcare® Lung apps.

3. Age ≥ 18 years.

4. Patient received anti-cancer treatment (surgery, chemotherapy, radiation (stereotaxyor not) or radio-chemotherapy association ended less than 12 weeks (Cohort 1post-treatment); or during maintenance treatment or consolidation by chemotherapy ortargeted therapy, or by immunotherapy initiated less than 12 weeks (Cohort 2 duringtreatment).

5. Imaging tumor evaluation less than 12 weeks showing disease control (response orstability according to RECIST 1.1 criteria).

6. Patient with symptomatic score on Moovcare® Lung apps less than 7.

7. Patient (or relatives) with internet access, a personnal e-mail box and asmartphone.

8. Patient with social security affiliation.

9. Signed informed consent form.

Exclusion Criteria:

1. Patient with progression after the first evaluation of initial treatment.

2. Pregnancy and breast-feeding.

3. Patient under tutorship or guardianship.

4. Dementia, mental alteration or psychiatric pathology influencing patient consentprocedure and/or protocol observance and study follow-up.

5. Patient enable to protocol follow-up for psychological, social, familial orgeographical reasons.